Randomized Controlled Trial to determine if the outcomes of sclerotherapy of the ulcer bed alone differ from a combination of ablation and sclerotherapy injections.
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Baseline Ulcer Healing Rate
Timeframe: Start of Treatment (Baseline)
3 Month Ulcer Healing Rate Change
Timeframe: 3 months following start of treatment
6 Month Ulcer Healing Rate Change
Timeframe: 6 months following start of treatment
Baseline Ulcer Size (Length)
Timeframe: Start of Treatment (Baseline)
Baseline Ulcer Size (Width)
Timeframe: Start of Treatment (Baseline)
Baseline Ulcer Size (Surface Area)
Timeframe: Start of Treatment (Baseline)
Baseline Ulcer Size (Depth)
Timeframe: Start of Treatment (Baseline)
Baseline Ulcer Size (Volume)
Timeframe: Start of Treatment (Baseline)
3 Month Ulcer Size (Length)
Timeframe: 3 months following start of treatment
3 Month Ulcer Size (Width)
Timeframe: 3 months following start of treatment
3 Month Ulcer Size (Surface Area)
Timeframe: 3 months following start of treatment
3 Month Ulcer Size (Depth)
Timeframe: 3 months following start of treatment
3 Month Ulcer Size (Volume)
Timeframe: 3 months following start of treatment
6 Month Ulcer Size (Length)
Timeframe: 6 months following start of treatment
6 Month Ulcer Size (Width)
Timeframe: 6 months following start of treatment
6 Month Ulcer Size (Surface Area)
Timeframe: 6 months following start of treatment
6 Month Ulcer Size (Depth)
Timeframe: 6 months following start of treatment
6 Month Ulcer Size (Volume)
Timeframe: 6 months following start of treatment
Baseline Clinical Evaluation
Timeframe: Start of Treatment (Baseline)
3 Month Clinical Evaluation; Change Assessment
Timeframe: 3 months following start of treatment
6 Month Clinical Evaluation; Change Assessment
Timeframe: 6 months following start of treatment
Baseline_ Venous Insufficiency Epidemiological and Economic Study- Quality of Life/Symptoms (VEINES-QOL/Sym)
Timeframe: Start of Treatment (Baseline)
3 Month_ Venous Insufficiency Epidemiological and Economic Study- Quality of Life/Symptoms (VEINES-QOL/Sym); Change Assessment
Timeframe: 3 months following start of treatment
6 Month_ Venous Insufficiency Epidemiological and Economic Study- Quality of Life/Symptoms (VEINES-QOL/Sym); Change Assessment
Timeframe: 6 months following start of treatment
Baseline_Venous Clinical Severity Score (VCSS)
Timeframe: Start of Treatment (Baseline)
3 Month_Venous Clinical Severity Score (VCSS); Change Assessment)
Timeframe: 3 months following start of treatment
6 Month_Venous Clinical Severity Score (VCSS); Change Assessment
Timeframe: 6 months following start of treatment